Valneva SE (VALN) Net Cash Flow (QoQ) (2021 - 2026)
Valneva SE (VALN) Net Cash Flow (QoQ) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
| 10 |
Valneva SE |
167.33 Mn |
44.10 Mn |
5.08 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
99.85% |
| Dec 31, 2025 |
-55.75% |
| Sep 30, 2025 |
-390.86% |
| Jun 30, 2025 |
58.99% |
| Mar 31, 2025 |
-206.14% |
| Dec 31, 2024 |
-99.95% |
| Sep 30, 2024 |
201.87% |
| Jun 30, 2024 |
-32,428.96% |
| Mar 31, 2024 |
216.80% |
| Dec 31, 2023 |
-100.05% |
| Sep 30, 2023 |
199.87% |
| Jun 30, 2023 |
-260,728.96% |
| Mar 31, 2023 |
-210.60% |
| Dec 31, 2022 |
138.68% |
| Sep 30, 2022 |
-399.14% |
| Jun 30, 2022 |
167.08% |
| Mar 31, 2022 |
-135.10% |
| Dec 31, 2021 |
216.95% |
| Sep 30, 2021 |
-185.35% |
| Jun 30, 2021 |
221.70% |
